Boehringer Ingelheim, Palatin Technologies to develop melanocortin receptor targeted treatment for retinal diseases

Maharashtra FDA Launches Special Drive to Inspect Liquid Oral Formulations

DRRA5 minutes ago 0

Sjögren’s disease prevalence higher in Alaska Native communities

DRRA43 minutes ago 0

RIMS Ranchi approves Rs 5000 aid for deceased patient’s kin

DRRA59 minutes ago 0

MCC to announce round 3 seat allotment results tomorrow

DRRA2 hours ago 0